Literature DB >> 15205590

D-dimer can predict survival in patients with chronic atrial fibrillation.

Isabelle Mahé1, Ludovic Drouet, Guy Simoneau, Sophie Minh-Muzeaux, Charles Caulin, Jean-François Bergmann.   

Abstract

High mean levels of D-dimers (DD), markers of fibrin product and degradation, have been reported in patients with atrial fibrillation. In order to determine the predictive value of DD, 125 consecutive patients (mean age, 78 years) with chronic atrial fibrillation without acute disease were prospectively included. DD were quantified by Liatest at inclusion. Patients were followed for a mean duration of 2 years. DD and age at inclusion were significantly higher in patients who would die (n = 54) than in those who would not (n = 65). After multiple analysis of variance, age was not significantly related to prognosis (P = 0.36); low DD (P = 0.03) and oral anticoagulant therapy (P = 0.0192) were independently related to survival. In conclusion, a single determination of DD can strongly predict survival over the following 2 years. It may contribute to the risk stratification and perhaps to the choice of the antithrombotic therapy in high-risk patients with elevated DD. Copyright 2004 Lippincott Williams and Wilkins

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15205590     DOI: 10.1097/01.mbc.0000114440.81125.bd

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  5 in total

1.  A clinical prediction model to estimate risk for 30-day adverse events in emergency department patients with symptomatic atrial fibrillation.

Authors:  Tyler W Barrett; Amy R Martin; Alan B Storrow; Cathy A Jenkins; Frank E Harrell; Stephan Russ; Dan M Roden; Dawood Darbar
Journal:  Ann Emerg Med       Date:  2010-08-21       Impact factor: 5.721

2.  Exposure-response for biomarkers of anticoagulant effects by the oral direct thrombin inhibitor AZD0837 in patients with atrial fibrillation.

Authors:  Gregory Y H Lip; Lars H Rasmussen; S Bertil Olsson; Eva Jensen; Bengt Hamrén; Ulf G Eriksson; Karin Wåhlander
Journal:  Br J Clin Pharmacol       Date:  2015-09-22       Impact factor: 4.335

3.  D-Dimer assay as a non invasive test for the diagnosis of left atrial Thrombi in Indian patients with Rheumatic MS.

Authors:  M Rajappa; T N Sunil Roy; A Raj; V Trehan; V Mallika
Journal:  Afr Health Sci       Date:  2013-09       Impact factor: 0.927

Review 4.  Stroke And Bleeding Risk Assessment: Where Are We Now?

Authors:  Mikhail S Dzeshka; Gregory Y H Lip
Journal:  J Atr Fibrillation       Date:  2014-04-30

5.  Relevance of transthoracic left atrial appendage wall velocity measurement in addition to left atrial volume for noninvasive and quantitative assessment of left atrial thrombogenesis in patients with atrial fibrillation and normal D-dimer levels.

Authors:  Naoyasu Yoshida; Mitsunori Okamoto; Hidekazu Hirao; Kazuyoshi Suenari; Kiyomi Nanba; Mio Uchida; Ryo Yamazato; Yuichiro Watari; Yukihiro Fukuda; Hironori Ueda
Journal:  J Med Ultrason (2001)       Date:  2015-12-14       Impact factor: 1.314

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.